Pharming Group (OTCMKTS:PHGUF) Shares Gap Up – What’s Next?

Pharming Group NV (OTCMKTS:PHGUF) shares gapped up prior to trading on Wednesday . The stock had previously closed at $1.20, but opened at $1.25. Pharming Group shares last traded at $1.25, with a volume of 200 shares.

Pharming Group Stock Performance

The business has a fifty day simple moving average of $1.46 and a 200-day simple moving average of $1.61. The company has a quick ratio of 2.06, a current ratio of 2.63 and a debt-to-equity ratio of 0.40. The firm has a market cap of $771.73 million, a P/E ratio of 57.53 and a beta of 0.45.

Pharming Group (OTCMKTS:PHGUF) last posted its quarterly earnings data on Thursday, May 7th. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter. The firm had revenue of $72.45 million during the quarter, compared to the consensus estimate of $92.06 million. Pharming Group had a return on equity of 4.64% and a net margin of 3.30%.

About Pharming Group

Pharming Group NV is a Netherlands-based biopharmaceutical company specializing in the development and commercialization of protein replacement therapies for rare diseases. Founded in 1988 and headquartered in Leiden, the company leverages transgenic technology to produce recombinant proteins, with its flagship product RUCONEST (recombinant C1 esterase inhibitor) indicated for the treatment of acute hereditary angioedema (HAE) attacks. RUCONEST is approved and marketed in the United States, Europe and several other territories through partnerships with leading specialty pharmaceutical companies.

Beyond RUCONEST, Pharming maintains a diversified pipeline targeting unmet needs in rare and ultra-rare disorders.